| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5958446 | NOVEN PHARMS INC | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Dec, 2012
(11 years ago) | |
| US5474783 | NOVEN PHARMS INC | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Dec, 2012
(11 years ago) | |
| US6024976 | NOVEN PHARMS INC | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Jan, 2014
(10 years ago) | |
| US5656286 | NOVEN PHARMS INC | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Aug, 2014
(9 years ago) | |
Combipatch is owned by Noven Pharms Inc.
Combipatch contains Estradiol; Norethindrone Acetate.
Combipatch has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Combipatch are:
- US5958446
- US5474783
- US6024976
- US5656286
Combipatch was authorised for market use on 07 August, 1998.
Combipatch is available in film, extended release;transdermal dosage forms.
The generics of Combipatch are possible to be released after 12 August, 2014.
Drugs and Companies using ESTRADIOL; NORETHINDRONE ACETATE ingredient
Market Authorisation Date: 07 August, 1998
Treatment: NA
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
More Information on Dosage
COMBIPATCH family patents
